Article
Myosin 1g as a high-risk biomarker in a pediatric patient with lineage switch from acute lymphoblastic leukemia to myeloid phenotype.
Boletin medico del Hospital Infantil de Mexico - 1 Jan 2023
Araujo-Cárdenas Janeth E, Rodríguez-Ruiz Miguel A, López-Valdez Jaime A, Rodríguez-Téllez Rosa I, Garfias-Gómez Yanelly, Parra-Ortega Israel, Patiño-López Genaro
Abstract excerpt
BACKGROUND: Myosin 1g (Myo1g) has recently been identified as a potential diagnostic biomarker in childhood acute lymphocytic leukemia (ALL). CASE REPORT: We describe the case of a 1-year-old Mexican female patient. Although initially studied for hepatomegaly, an infectious or genetic etiology was excluded. Liver biopsy showed infiltration by neoplastic B-cell precursors (BCPs), and bone marrow (BM) aspirate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.